Literature DB >> 1612232

Islet cell antibodies in normal French schoolchildren.

C Lévy-Marchal1, J Tichet, I Fajardy, X F Gu, F Dubois, P Czernichow.   

Abstract

Islet-cell antibodies have been reported to be of predictive value for the future development of Type 1 (insulin-dependent) diabetes in first degree relatives of diabetic patients with the risk increasing in these subjects with the islet-cell antibodies titre. However, very little is known about islet-cell antibodies in background populations. Sera (n = 8363) from schoolchildren (6-17 years) in the French background population were screened for the presence of islet-cell antibodies by the indirect immunofluorescence technique. Islet-cell antibodies greater than 4.5 Juvenile Diabetes Foundation units were found in 150 sera (prevalence rate 1.8%; 95% confidence interval 1.5-2.1%). Only 17 sera demonstrated islet-cell antibody titre greater than or equal to 24 JDF units. No particular feature was found to be significantly different between islet-cell antibody-positive and islet-cell antibody-negative children (age, family history of diabetes, fasting plasma glucose, insulin autoantibodies). A second blood sample was obtained from 80 of 150 islet-cell antibody positive children after a mean interval of 8 months. Only 11 sera became less than 4.5 JDF units with islet-cell antibody titres being stable in the remaining sera, including the high-titre positive sera (greater than or equal to 24 JDF units). HLA-DQB typing was performed by restriction mapping techniques in 80 islet-cell antibody-positive, in 93 islet-cell antibody-negative and in 213 Type 1 diabetic children. The distribution of the susceptibility alleles (DQB1-Asp57-negative) was not significantly different between islet-cell antibody-positive and islet-cell antibody-negative children.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1612232     DOI: 10.1007/bf00400487

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  35 in total

1.  Superiority of radiobinding assay over ELISA for detection of IAAs in newly diagnosed type I diabetic children.

Authors:  C Levy-Marchal; M P Bridel; F Sodoyez-Goffaux; M Koch; J Tichet; P Czernichow; J C Sodoyez
Journal:  Diabetes Care       Date:  1991-01       Impact factor: 19.112

2.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

3.  A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes.

Authors:  W J Riley; N K Maclaren; J Krischer; R P Spillar; J H Silverstein; D A Schatz; S Schwartz; J Malone; S Shah; C Vadheim
Journal:  N Engl J Med       Date:  1990-10-25       Impact factor: 91.245

4.  Incidence of type 1 (insulin-dependent) diabetes mellitus in Catalonia, Spain. The Catalan Epidemiology Diabetes Study Group.

Authors:  A Goday; C Castell; R Tresserras; J Canela; J L Taberner; G Lloveras
Journal:  Diabetologia       Date:  1992-03       Impact factor: 10.122

5.  Application of silver staining to the rapid typing of the polymorphism of HLA-DQ alleles by enzymatic amplification and allele-specific restriction fragment length polymorphism.

Authors:  L Y Ju; X F Gu; E Larger; R Krishnamoorthy; D Charron
Journal:  Electrophoresis       Date:  1991-04       Impact factor: 3.535

6.  Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients.

Authors:  C Thivolet; B Beaufrère; L Geburher; P Chatelain; J Orgiazzi; R François
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

7.  Clinical time-course and characteristics of islet cell cytoplasmatic antibodies in childhood diabetes.

Authors:  G J Bruining; J Molenaar; C W Tuk; J Lindeman; H A Bruining; B Marner
Journal:  Diabetologia       Date:  1984-01       Impact factor: 10.122

8.  Evidence that type I diabetes and thyrogastric autoimmunity have different genetic determinants.

Authors:  A N Gorsuch; B M Dean; G F Bottazzo; J Lister; A G Cudworth
Journal:  Br Med J       Date:  1980-01-19

9.  Diabetes mellitus among first- and second-degree relatives of early onset diabetics.

Authors:  B Degnbol; A Green
Journal:  Ann Hum Genet       Date:  1978-07       Impact factor: 1.670

10.  Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.

Authors:  E Bonifacio; P J Bingley; M Shattock; B M Dean; D Dunger; E A Gale; G F Bottazzo
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

View more
  7 in total

Review 1.  Immune intervention yes, but for what reason, for whom, when and how?

Authors:  A Lernmark
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

2.  The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity.

Authors:  Robert Hermann; A P Laine; R Veijola; T Vahlberg; S Simell; J Lähde; O Simell; M Knip; J Ilonen
Journal:  Diabetologia       Date:  2005-07-16       Impact factor: 10.122

3.  Anti-37kDa antibodies are associated with the development of IDDM in individuals with islet cell antibodies.

Authors:  J C Ongagna; C Levy-Marchal
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

4.  Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives.

Authors:  D Schatz; J Krischer; G Horne; W Riley; R Spillar; J Silverstein; W Winter; A Muir; D Derovanesian; S Shah
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

5.  Combined analysis of islet cell antibodies which cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM.

Authors:  L Chaillous; M Delamaire; A Elmansour; D Maugendre; V Rohmer; M G Joseph; P Lecomte; J M Limal; B Charbonnel; H Allannic
Journal:  Diabetologia       Date:  1994-05       Impact factor: 10.122

6.  HLA-DQ screening for risk assessment of insulin dependent diabetes in northern Italy.

Authors:  V Lampasona; M Ferrari; E Bonifacio; M R Pastore; P Carrera; A Sergi; S Genovese; M Trucco; J Dorman; E Bosi
Journal:  Acta Diabetol       Date:  1995-10       Impact factor: 4.280

7.  Molecular biology of IDDM.

Authors:  A Lernmark
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.